SLS · SELLAS Life Sciences Group, Inc.
$12.48
-0.71 (-5.38%)
At close · Jul 20
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of Financial Statements - Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. The Company expects its cash and cash equivalents, together with the $7.5 million in proceeds from warrant exercises subsequent to March 31, 2026, will be sufficient to fund its current planned operations for at least the next twelve months from the date of issuance of these consolidated financial statements, although the Company may pursue additional capital resources through public or private equity or debt financings or by entering into additional license agreements or collaborations with other companies.”View the 10-Q filed May 12, 2026
Market Cap
$2.32B
Shares
186.03M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 3,634 | $15.45 | $56,145 |
| 2026-06-29 | 394,933 | $12.39 | $4,893,220 |
| 2026-06-26 | 229,096 | $10.53 | $2,412,381 |
| 2026-06-25 | 436,825 | $9.17 | $4,005,685 |
| 2026-06-24 | 1,063,738 | $9.07 | $9,648,104 |
| 2026-06-23 | 810,228 | $8.53 | $6,911,245 |
| 2026-06-22 | 1,920,359 | $8.05 | $15,458,890 |
| 2026-06-18 | 94,929 | $7.76 | $736,649 |
| 2026-06-17 | 35,302 | $7.53 | $265,824 |
| 2026-06-16 | 221,763 | $7.73 | $1,714,228 |
| 2026-06-15 | 52,019 | $7.83 | $407,309 |
| 2026-06-12 | 216,790 | $7.75 | $1,680,123 |
| 2026-06-11 | 7,816 | $7.15 | $55,884 |
| 2026-06-10 | 6,338 | $7.68 | $48,676 |
| 2026-06-09 | 209 | $7.98 | $1,668 |
| 2026-06-08 | 174,013 | $8.23 | $1,432,127 |
| 2026-06-05 | 74,530 | $9.04 | $673,751 |
| 2026-06-04 | 63,389 | $8.19 | $519,156 |
| 2026-06-03 | 32,577 | $8.33 | $271,366 |
| 2026-06-02 | 6,679 | $9.07 | $60,579 |
| 2026-06-01 | 258,769 | $9.31 | $2,409,139 |
| 2026-05-29 | 844,627 | $9.18 | $7,753,676 |
| 2026-05-28 | 709,167 | $8.58 | $6,084,653 |
| 2026-05-27 | 97,692 | $8.12 | $793,259 |
| 2026-05-26 | 676,114 | $7.78 | $5,260,167 |
| 2026-05-22 | 998,309 | $7.56 | $7,547,216 |
| 2026-05-21 | 7,951 | $8.97 | $71,320 |
| 2026-05-20 | 3,000 | $7.59 | $22,770 |
| 2026-05-19 | 3,000 | $7.29 | $21,870 |
| 2026-05-18 | 3,575 | $7.08 | $25,311 |
| 2026-05-15 | 21,663 | $7.42 | $160,739 |
| 2026-05-14 | 84,995 | $6.53 | $555,017 |
| 2026-05-13 | 9,124 | $5.22 | $47,627 |
| 2026-05-12 | 7,725 | $5.25 | $40,556 |
| 2026-05-11 | 19,456 | $5.01 | $97,475 |
| 2026-05-08 | 105,148 | $4.93 | $518,380 |
| 2026-05-07 | 38,467 | $5.15 | $198,105 |
| 2026-05-06 | 3,285 | $4.87 | $15,998 |
| 2026-05-05 | 5,463 | $5.02 | $27,424 |
| 2026-05-01 | 19,634 | $4.95 | $97,188 |
| 2026-04-30 | 352,085 | $4.67 | $1,644,237 |
| 2026-04-29 | 2,436 | $4.88 | $11,888 |
| 2026-04-28 | 10,959 | $4.88 | $53,480 |
| 2026-04-27 | 29,045 | $4.46 | $129,541 |
| 2026-04-24 | 68,104 | $4.64 | $316,003 |
| 2026-04-23 | 32,501 | $4.78 | $155,355 |
| 2026-04-21 | 19,489 | $4.99 | $97,250 |
Showing 1–47 of 47 settlements
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
19 filings
19 filers
Visit website
Investor relations